N. N. Stanley
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
-
- Neuroscience of respiration and sleep
Papers in
-
- Neuroscience of respiration and sleep 9
-
- Respiratory Support and Mechanisms 12
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Co-authors
- Neil S. CherniackMurray D. AltoseA. P. FishmanSteven G. KelsenNeil McIntyreJames A. TurnerM. D. AltoseJudith M. Hughes
- Journals
- Thorax (7 papers)Journal of Applied Physiology (7 papers)Journal of Clinical Investigation (2 papers)Drugs (2 papers)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
N. N. Stanley
35 papers receiving 710 citations
Peers
Comparison fields: 5 of 78
- Hepatology 178
- Endocrine and Autonomic Systems 113
- Pulmonary and Respiratory Medicine 406
- Anesthesiology and Pain Medicine 46
- Physiology 141
Countries citing papers authored by N. N. Stanley
This map shows the geographic impact of N. N. Stanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. N. Stanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. N. Stanley more than expected).
Fields of papers citing papers by N. N. Stanley
This network shows the impact of papers produced by N. N. Stanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. N. Stanley. The network helps show where N. N. Stanley may publish in the future.
Co-authors
The 25 scholars most cited alongside N. N. Stanley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | Gaboxadol reduces the detrimental effects of traffic noise on sleep: A randomised, double-blind, placebo-controlled, parallel group study in healthy subjects | 2007 | 1 |
| 4 | A placebo controlled, randomised, double-blind, 4 way cross-over study of 3 doses of EVT201 (2.5mg, 5mg and 10mg) on aspects of sleep and morning after performance using a traffic noise model of sleep disturbance | 2006 | 1 |
| 5 | 2001 | 12 | |
| 6 | 1988 | 16 | |
| 7 | 1988 | 12 | |
| 8 | 1988 | 35 | |
| 9 | 1983 | 11 | |
| 10 | 1976 | 23 | |
| 11 | 1976 | 29 | |
| 12 | 1975 | 21 | |
| 13 | 1975 | 23 | |
| 14 | 1973 | 20 | |
| 15 | 1972 | 50 | |
| 16 | 1972 | 26 | |
| 17 | 1971 | 47 | |
| 18 | 1971 | 85 | |
| 19 | 1971 | 18 | |
| 20 | 1970 | 16 |
About N. N. Stanley
N. N. Stanley is a scholar working on Endocrine and Autonomic Systems, Pulmonary and Respiratory Medicine, Anesthesiology and Pain Medicine, Neurology and Hepatology, having authored 37 papers that have together received 810 indexed citations. Recurring topics across this work include Respiratory Support and Mechanisms (12 papers), Neuroscience of respiration and sleep (9 papers), Heart Rate Variability and Autonomic Control (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Blood Pressure and Hypertension Studies (3 papers), Noise Effects and Management (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Hepatology (178 citations), Endocrine and Autonomic Systems (113 citations), Pulmonary and Respiratory Medicine (406 citations), Anesthesiology and Pain Medicine (46 citations) and Physiology (141 citations). N. N. Stanley has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Neil S. Cherniack, Murray D. Altose, A. P. Fishman, Steven G. Kelsen, Neil McIntyre, James A. Turner, M. D. Altose, Judith M. Hughes, F Ruff and Richard E. Greene. Their work appears in journals such as Thorax, Journal of Applied Physiology, Journal of Clinical Investigation, Drugs and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.